Literature DB >> 29799289

Bronchodilator Responses in Respiratory Impedance, Hyperinflation and Gas Trapping in COPD.

Stephen Milne1,2,3, Christoph Hammans1, Stella Watson1, Claude S Farah1,2,4, Cindy Thamrin1, Gregory G King1,3,5.   

Abstract

Hyperinflation, gas trapping and their responses to long-acting bronchodilator are clinically important in COPD. The forced oscillation technique (FOT) measures of respiratory system resistance and reactance are sensitive markers of bronchodilator response in COPD. The relationships between changes in resistance and reactance, and changes in hyperinflation and gas trapping, following long-acting bronchodilator (LA-BD) have not been studied. 15 subjects with mild-moderate COPD underwent FOT, spirometry then body plethysmography, before and 2 hours after a single 150 microg dose of the LA-BD indacaterol. Hyperinflation was quantified as the inspiratory capacity to total lung capacity ratio (IC/TLC), and gas trapping as residual volume to TLC ratio (RV/TLC). At baseline, FOT parameters were moderately correlated with IC/TLC (|r| 0.53-0.73, p < 0.05). At 2 hours post-LA-BD, there were moderate correlations between change in FOT and change in RV/TLC (|r| 0.60-0.82, p < 0.05). Baseline FOT parameters also correlated with the subsequent post-LA-BD change in both IC/TLC (|r| 0.54-0.62, p < 0.05) and RV/TLC (|r| 0.57-0.76, p < 0.05). FOT impedance reflects hyperinflation and gas trapping in COPD, and the potential for long-acting bronchodilator responsiveness. These results provide us with further insight into the physiological mechanisms of action of long-acting bronchodilator treatment, and may be clinically useful for predicting treatment responses.

Entities:  

Keywords:  Airways disease; forced oscillation technique; indacaterol; lung mechanics

Mesh:

Substances:

Year:  2018        PMID: 29799289     DOI: 10.1080/15412555.2018.1458217

Source DB:  PubMed          Journal:  COPD        ISSN: 1541-2563            Impact factor:   2.409


  7 in total

Review 1.  Lung Function Assessment by Impulse Oscillometry in Adults.

Authors:  Noemi Porojan-Suppini; Ovidiu Fira-Mladinescu; Monica Marc; Emanuela Tudorache; Cristian Oancea
Journal:  Ther Clin Risk Manag       Date:  2020-11-26       Impact factor: 2.423

2.  Usefulness of impulse oscillometry for the assessment of bronchodilator response in elderly patients with chronic obstructive airway disease.

Authors:  Jin-Han Park; Jae Ha Lee; Hyo-Jung Kim; Nari Jeong; Hang-Jea Jang; Hyun-Kuk Kim; Chan Sun Park
Journal:  J Thorac Dis       Date:  2019-04       Impact factor: 2.895

3.  Clinical impact of long-term change in air trapping on pulmonary function and computed tomography parameters in chronic obstructive pulmonary disease.

Authors:  Jeong Uk Lim; Jae Seung Lee; Ji-Hyun Lee; Sang-Do Lee; Yeon-Mok Oh; Chin Kook Rhee
Journal:  Korean J Intern Med       Date:  2020-11-25       Impact factor: 2.884

Review 4.  Oscillometry of the respiratory system: a translational opportunity not to be missed.

Authors:  Lennart K A Lundblad; Annette Robichaud
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-04-06       Impact factor: 5.464

5.  Comparison of impedance measured by the forced oscillation technique and pulmonary functions, including static lung compliance, in obstructive and interstitial lung disease.

Authors:  Naoya Takeichi; Haruna Yamazaki; Keisaku Fujimoto
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2019-05-24

6.  Relationships Between Forced Oscillatory Impedance and 6-minute Walk Distance After Pulmonary Rehabilitation in COPD.

Authors:  Sabine C Zimmermann; Cindy Thamrin; Andrew Sl Chan; Amy Bertolin; David G Chapman; Gregory G King
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-01-21

7.  Air Trapping and the Risk of COPD Exacerbation: Analysis From Prospective KOCOSS Cohort.

Authors:  Youlim Kim; Sang Hyuk Kim; Chin Kook Rhee; Jae Seung Lee; Chang Youl Lee; Deog Kyeom Kim; Kyeong-Cheol Shin; Ki Suck Jung; Kwang Ha Yoo; Yong Bum Park
Journal:  Front Med (Lausanne)       Date:  2022-03-11
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.